Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Elizabeth A. Hoge, MD
JCP
Original Research
MBCT for Depression in Patients With Chronic Pain
February 28, 2017
Depression is highly prevalent in patients with chronic pain. Mindfulness-based therapies show initial promise for both depression and chronic pain individually but have not been tested in patients with...
Marasha de Jong
,
Frenk Peeters
,
Tim Gard
, et al
JCP
Original Research
Mindfulness Meditation for Anxiety
March 13, 2013
Read a randomized controlled on the Trial of Mindfulness Meditation for Generalized Anxiety Disorder and the Effects on Anxiety and Stress Reactivity.
Elizabeth A. Hoge
,
Eric Bui
,
Luana Marques
, et al
JCP
Original Research
Eszopiclone for PTSD & Insomnia Treatment
February 22, 2011
Read the full study on whether pharmacotherapy with eszopiclone improved short-term in PTSD severity and associated sleep disturbance
Mark H. Pollack
,
Elizabeth A. Hoge
,
John J. Worthington
, et al
JCP
Original Research
Next-Step Strategies for Panic Disorder Refractory to Initial Pharmacotherapy: A 3-Phase Randomized Clinical Trial
October 6, 2009
Naomi M. Simon
,
Michael W. Otto
,
John J. Worthington
, et al
JCP
Original Research
An Open-Label Trial of Risperidone Augmentation for Refractory Anxiety Disorders
March 15, 2006
Naomi M. Simon
,
Elizabeth A. Hoge
,
Diana Fischmann
, et al
JCP
Original Research
An Open-Label Study of Levetiracetam for the Treatment of Social Anxiety Disorder
September 1, 2004
Naomi M. Simon
,
John J. Worthington
,
Alicia C. Doyle
, et al